Sauran Yerdessov

Mr. Sauran Yerdessov

Research Assisstant
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Sauran YerdessovSauran Yerdessov
Sauran Yerdessov
KKKainar Kadyrzhanuly
Kainar Kadyrzhanuly
YSYesbolat Sakko
Yesbolat Sakko
AGArnur Gusmanov
Arnur Gusmanov
GZGulnur Zhakhina
Gulnur Zhakhina
AGAbduzhappar Gaipov
Abduzhappar Gaipov
The in-depth epidemiology of hypertension has not been studied in Kazakhstan (KZ) yet. We aimed to investigate the crude; age and sex standardized prevalence, incidence, and all-cause mortality rate among hypertensive patients in Kazakhstan using a large-scale Unified National Electronic Health System (UNEHS) for the period 2014–2019. Hypertension was defined based on the ICD-10 codes (ICD-code: I10; I11; I12; I13). Of 1,908,419 patients, 1,186,706 (62.18%) were females and 721,713 (37.82%) were males. The majority of the patients (56.3%) were ethnic Kazakhs, 26.6% were Russians, and 16.2% were of other ethnicities. In 2014, the crude rates of prevalence, incidence, and mortality were 3661, 1396.1, and 33.1 per 100,000 population, respectively. The overall prevalence, incidence, and mortality rates among hypertension patients had a gradual increase over the period 2014–2019. The sex and age adjusted rates demonstrate the same trend throughout the entire period. We observed 71% higher risk of crude death in males comparing to females (Hazard ratio (HR): 1.71 [95%CI: 1.69–1.72]); Russian and other ethnicities had 1.56-fold (95%CI: 1.54–1.58 and 1.43-fold (95%CI: 1.41–1.45) higher risk of all-cause death compared to Kazakhs, and the elderly group had the highest risk of death (Hazard ratio (HR): 35.68 [95%CI: 28.11–45.31]) comparing to the younger generation, which remained significant after adjustment to age and sex. Overall, these findings show statistically significant lower survival probability in male patients compared to female, in older patients compared to younger ones, and in patients of Russian and other ethnicities compared to Kazakh.

14 January 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
GZGulnur Zhakhina
Gulnur Zhakhina
AGArnur Gusmanov
Arnur Gusmanov
YSYesbolat Sakko
Yesbolat Sakko
Sauran YerdessovSauran Yerdessov
Sauran Yerdessov
YSYuliya Semenova
Yuliya Semenova
AGAbduzhappar Gaipov
Abduzhappar Gaipov
A Global Burden of Disease (GBD) study reported that 9.6 million years lived with disability (YLDs) were lost due to hip and knee osteoarthritis (KOA) in 2017. Although the GBD study presents the disease burden at the global level, there is no information on any Central Asian country. This study aims to investigate the epidemiology of knee osteoarthritis in Kazakhstan. The data of 56,895 people with KOA between 2014–2020 was derived from the Unified National Electronic Health System of Kazakhstan and retrospectively analyzed. The majority of the cohort (76%) were women, of Kazakh ethnicity (66%), and older than 50 years of age (87%). The risk of gonarthrosis escalated for women after 50 years and peaked at 75 years with a rate of 3062 females admitted to hospital per 100,000 women in the population. This observation is approximately three times higher than for men of the same age group. A geographical analysis showed that the Jambyl oblast, West Kazakhstan, North Kazakhstan, and the Akmola oblast have the highest burden of disease. During the observation period, 127,077 age-adjusted YLDs were lost due to knee osteoarthritis. This is the first study in Kazakhstan to investigate the burden of knee osteoarthritis. This research recognizes age and sex-based differences, and regional disparities in the incidence of knee osteoarthritis. This knowledge can lead to the development of more specific diagnostic approaches and gender-personalized therapy protocols for patients.

1 January 2023 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
PDF file
Sauran YerdessovSauran Yerdessov
Sauran Yerdessov
AAAnara Abbay
Anara Abbay
ZMZhalaliddin Makhammajanov
Zhalaliddin Makhammajanov
AZAygerim Zhuzzhasarova
Aygerim Zhuzzhasarova
AGArnur Gusmanov
Arnur Gusmanov
AGAbduzhappar Gaipov
Abduzhappar Gaipov
Background: Vaccine-preventable diseases such as pertussis, measles, and influenza remain among the most significant medical and socioeconomic issues in Kazakhstan, despite significant vaccination achievements. Thus, here we aimed to analyze the long-term dynamics and provide information on the current epidemiology of pertussis, measles, and influenza in Kazakhstan. Methods: A retrospective analysis of the long-term dynamics of infectious diseases was carried out using the data from the statistical collections for 2010-2020 and the Unified Payment System from 2014 to 2020. Results: During the 2010-2020 years, the long-term dynamics show an unequal distribution of pertussis, measles, and influenza-related morbidity. In comparison with earlier years, registration of infectious disease was the highest in 2019 and 2020. The incidence cases among registered infectious diseases in 2019 were: pertussis-147, measles-13,326, and in 2020: influenza-2,678. High incidence rates have been documented in Pavlodar, North Kazakhstan, Mangystau regions, and the cities of Shymkent and Nur-Sultan. The incidence varies depending on the seasonality: pertussis (summer-autumn), measles (winter-spring), and influenza (mostly in winter). Conclusion: The findings highlight the importance of focusing more on the characteristics of the epidemic process of vaccine-preventable diseases in order to assess the effectiveness of implemented measures and verify new routes in strengthening the epidemiological surveillance system.

23 August 2024 in Biology
Verified
Journal Article
Open access
PDF file
LKLyazzat Kaldygulova
Lyazzat Kaldygulova
Sauran YerdessovSauran Yerdessov
Sauran Yerdessov
TUTalshyn Muchadesovna Ukybassova
Talshyn Muchadesovna Ukybassova
YKYevgeniy Kim
Yevgeniy Kim
DADinmukhamed Ayaganov
Dinmukhamed Ayaganov
AGAndrey Gaiday
Andrey Gaiday
Introduction: Preeclampsia is a severe multifactorial complication of pregnancy. Studies found associations between folate metabolism genes’ polymorphisms and preeclampsia. However, investigations in this field are limited among Asian populations. Thus, the study’s aim was to evaluate the prevalence of methionine synthase (MTR), methionine synthase reductase (MTRR), and methylenetetrahydrofolate reductase (MTHFR) genes’ polymorphisms among ethnic Kazakh women with preeclampsia. Methods: This was a retrospective study involving 4246 patients’ data for the period of 2018–2022. Identification of MTR, MTRR, and MTHFR genes’ polymorphism was performed via PR-PCR. Peripheral blood samples were obtained for the analyses. In total, 4246 patients’ data of Kazakh ethnicity with preeclampsia at >20 weeks gestational age who had undergone an investigation to identify polymorphisms of the folate metabolism pathway genes for the period of 5 years were included in this study. Results: The most common and prevalent mutation was the MTRR A66G polymorphism: 24.5% of all tested patients with preeclampsia had the MTRR A66G polymorphism. It was highest among the 35–39 age group participants. The second most prevalent was the MTHFR C677T polymorphism: 9% of women with preeclampsia had the MTHFR C677T mutation. It was highest among women aged 30–34. There was a rare association of the MTR A2756G mutation with preeclampsia among the study participants. Conclusions: The identified levels of MTRR A66G and MTHFR C677T polymorphisms among the study participants suggest the importance of evaluating MTRR and MTHFR polymorphisms in women with preeclampsia. The role of the MTR A2756G polymorphism in the development of preeclampsia needs to be further investigated.

24 December 2024 in Electronic Journal of General Medicine
Verified
Journal Article
Closed access
IAIliyar Arupzhanov
Iliyar Arupzhanov
DSDmitriy Syssoyev
Dmitriy Syssoyev
AAAidar Alimbayev
Aidar Alimbayev
GZGulnur Zhakhina
Gulnur Zhakhina
YSYesbolat Sakko
Yesbolat Sakko
AGAbduzhappar Gaipov
Abduzhappar Gaipov
Background and objective: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major contributors to chronic viral hepatitis (CVH), leading to significant global health mortality. This study aims to predict the one-year mortality in patients with CVH using their demographics and health records. Methods: Clinical data from 82,700 CVH patients diagnosed with HBV or HCV between January 2014 and December 2019 was analyzed. We developed a machine learning (ML) platform based on six broad categories including linear, nearest neighbors, discriminant analysis, support vector machine, naïve Bayes, and ensemble (gradient boosting, AdaBoost, and random forest) models to predict the one-year mortality. Feature importance analysis was performed by computing SHapley Additive exPlanations (SHAP). Results: The models achieved an area under the curve between 0.74 and 0.8 on independent test sets. Key predictors of mortality were age, sex, hepatitis type, and ethnicity. Conclusion: ML with administrative health data can be utilized to accurately predict one-year mortality in CVH patients. Future integration with detailed laboratory and medical history data could further enhance model performance.

1 October 2023 in European Journal of Public Health
Verified
Journal Article
Open access
PDF file
Sauran YerdessovSauran Yerdessov
Sauran Yerdessov
IAI Arupzhanov
I Arupzhanov
TAT Aimyshev
T Aimyshev
ZMZ Makhammajanov
Z Makhammajanov
SKS Kadyrov
S Kadyrov
AGA Gaipov
A Gaipov
Tuberculosis (TB) is a major cause of morbidity and mortality worldwide. The seasonal autoregressive integrated moving average (SARIMA) model is widely used for forecasting infectious disease incidence, including TB. However, there is a lack of comprehensive research on TB epidemiology and predictions for the future in Kazakhstan. Therefore, this study adopted a time series analysis of 72 monthly observations of reported TB cases in Kazakhstan from 2014-2019. The study used monthly health data from 2014-2019 for TB cases obtained from large-scale administrative records. The methodology involved using the Augmented Dickey-Fuller test for determining stationarity, ACF and PACF for identifying model parameters, and AIC/BIC for selecting the best SARIMA model, which was evaluated based on R2 score, MAE, and MAPE. The modeling dataset comprised monthly TB notification rates from 2014 to 2018, while the forecasting dataset comprised data from 2019. The findings suggest that the SARIMA model demonstrated some efficacy in predicting TB notification rates, although there remains scope for enhancing its precision. The time series was stationary after the first difference (ADF test: t-value of -3.25, P < 0.001) and not a white noise (P < 0.01). Based on ACF and PACF graphs, a SARIMA (0,1,0) (0,1,0)12 model was deemed to be the most appropriate forecasting model, with an R2 score of 0.43, MAE of 89.73 and MAPE of 0.08. To develop effective forecasting models for TB incidence, this study examined monthly TB cases in Kazakhstan from 2014 to 2019 and analyzed the seasonal patterns of TB occurrence. It is important to note that these results are preliminary and necessitate additional validation. Future studies will include correlation analyses between TB cases and meteorological data, using more recent data for TB cases, and evaluating various TB incidence forecasting models. Key messages: • A SARIMA model developed for TB in Kazakhstan showed decreasing trend using time series analysis. • Evidence-based strategies for TB prevention & control, and importance of monitoring & forecasting TB incidence highlighted in this study.